Central haemodynamic effects of dihydroergotamine in patients with orthostatic hypotension.
D000293:Adolescent; D000328:Adult; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D004562:Electrocardiography; D004878:Ergotamine / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy*; D007201:Indicator Dilution Techniques; D008365:Manometry; D008875:Middle Aged; D013448:Sulfobromophthalein
D013448:Sulfobromophthalein; D004878:Ergotamine